CONCORD HC GP (02453) Enters New Agreement with Mayo Clinic, Broadening Collaboration to Full Lifecycle Health Services

Stock News
Apr 22

CONCORD HC GP (02453) has announced the formal signing of a new cooperation agreement with the Mayo Foundation for Medical Education and Research (Mayo Clinic). Under this agreement, the scope of collaboration will expand from the internationalization and standardization of oncology diagnosis and treatment to encompass full lifecycle health services. These services will include disease prevention, screening, rehabilitation, and long-term health management.

Building on their previous cooperation in areas such as proton therapy talent development, cross-border consultations, patient referrals, hospital management, and international quality control, the two parties will now extend their partnership beyond oncology to cover preventive care, screening, rehabilitation, and comprehensive health management across a patient's lifespan.

Mayo Clinic will support the company by introducing its health management service system, operational standards, and clinical experience through methods such as remote planning, coaching, on-site assessments, and continuous optimization. This collaboration is expected to help CONCORD HC GP establish a complete service loop that integrates front-end prevention and screening, mid-end precision diagnosis and treatment, and back-end rehabilitation management. It aims to enhance the company's medical service capabilities, operational efficiency, and patient experience, thereby strengthening the group's core competitiveness and aligning with the interests of the company and all its shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10